期刊文献+

立体定向放射治疗在结直肠癌肝转移中的临床应用 被引量:2

Clinical application of stereotactic body radiation therapy for colorectal cancer with liver metastases
原文传递
导出
摘要 目的 评价立体定向放射治疗(SBRT)在结直肠癌肝转移(CLM)中的治疗效果,为合理选择治疗手段提供依据。方法 解放军306医院收治的28例患者,包括男17例,女11例,中位年龄63.8岁(31~86岁),共计54个病灶,行立体定向放射治疗。平静呼吸状态下的CT增强扫描影像分别进行大体肿瘤体积(GTV)、临床靶区体积(CTV)和计划靶区体积(PTV)的勾画,CTV为GTV外放5 mm,GTV为CTV外放5~10 mm。以50%~60%等剂量曲线作为处方剂量曲线,单次3~6 Gy,总剂量39~45 Gy,等效生物剂量50.7~65.3 Gy。治疗后3个月开始复查,以增强CT或MR显示的病灶体积的变化做为评价疗效的依据。根据RTOG毒性诊断标准对不良反应进行诊断和分级,比较局控率和生存率。结果 所有患者均顺利完成治疗,中位随访时间为15.1个月(3~30个月),随访终点有7例患者存活。局控率为79.2%,1年和2年的总生存率分别为82.7%和48.6%。病灶体积与局控率关系密切,当体积小于14 cm3时,肿瘤局控率明显高于病灶体积大于65 cm3时(χ2 = 4.17,P〈0.05)。病灶体积大于180 cm3时,肿瘤局控率为零。不良反应包括治疗后乏力(60.7%),1、2级消化道反应(28.6%),一过性1、2级骨髓抑制(46.4%),一过性转氨酶增高(17.8%)。全组未发生3级以上及晚期不良反应。结论 立体定向放射治疗可做为选择性病例尤其是不能手术的结直肠癌肝转移患者的首选局部治疗手段。 Objective To evaluate the efficacy of stereotactic body radiation therapy (SBRT) for hepatic metastases from colorectal cancer, and to collect data for the application of this technique. Methods A total of 28 patients from No. 306 Hospital of PLA, including 17 male and 11 female with median age of 63.8 (range from 31 to 86), were treated with SBRT for colorectal cancer with liver metastases with 54 lesions in total. The GTV,CTV and PTV were delineated above the enhanced CT scans acquired during normal quiet respiration. CTV was obtained by adding 5 mm isotropic margin from GTV, and PTV was obtained by adding 5 to 10 mm isotropic margin from CTV. Prescription dose line covered 50%-60% of isodose curve at 3-6 Gy/fraction. The total dose was 39-45 Gy and the biologically equivalent doses(BED)was 50.7-65.3 Gy. The patients were followed-up beginning at 3 months after SBRT. The change in size of the lesion based on enhanced CT or MR scans was evaluated. Toxicity was evaluated and scored according to the RTOG criteria. Local control rate and survival rate were analysed. Results All patients completed the treatment. With median follow-up of 15.1 months (range frome 3 to 30 months), 7 patients survived at the end of follow-up. The local control rate (LC) was 79.2%, and 1-and 2-year overall survival rate(OS) were 82.7% and 48.6%, respectively. There was a close corelation between the size of lesion and the LC. The LC(PR+CR)was much better at the size of lesion less than 14 cm3 than that at the size more than 65 cm3(χ2= 4.17, P〈0.05). When the size was more than 180 cm3, the LC was zero. Toxicity included fatigue(60.7%),grade 1 and 2 digestive system toxicity(28.6%),a transient grade 1 and 2 bone marrow suppression(46.4%) and a transient increase in transaminase(17.8%). No grade 3 toxicity and above and late toxicity were observed. Conclusions Stereotactic body radiation therapy could be suggested as the first choice for the selected patients who suffer form colorectal l
出处 《中华放射医学与防护杂志》 CAS CSCD 北大核心 2013年第6期626-629,共4页 Chinese Journal of Radiological Medicine and Protection
关键词 立体定向放射治疗 结直肠癌肝转移 临床应用 Stereotactic body radiation therapy Colorectal cancer with liver metastases Clinical application
  • 相关文献

参考文献16

  • 1Dawood 0,Mahadevan A, Goodman KA. . Stereotactic bodyradiation therapy for liver metastases. Eur J Cancer. 2009 ,45?17) :2947-2959. 被引量:1
  • 2Turzer M , Brustugun OT, Waldeland E, et al. Stereotactic bodyradiation therapy is effective and safe in patients with early-stagenon-small cell lung cancer with low performance status and severecomorbidity. Case Rep Oncol,2011,4(1) :25-34. 被引量:1
  • 3Fong Y, Fortner J, Sun RL, et al. Clinical score for predictingrecurrence after hepatic resection for metastatic colorectal cancer:analysis of 1001 consecutive cases. Ann Surg, 1999 ,230 ( 3 ):309-318. 被引量:1
  • 4Lochan R, White SA, Manas DM. Liver resection for colorectalliver metastasis. Surg Oncol, 2007 ,16(1) :3345. 被引量:1
  • 5Choti MA, Sitzmann JV , Tiburi MF, et al. Trends in long-termsurvival following liver resection for hepatic colorectal metastases.Ann Surg, 2002,235(6) :759-766. 被引量:1
  • 6Schefter TE, Kavanagh BD. Radiation therapy for livermetastases. Semin Radiat Oncol,2011,21(4) :264-270. 被引量:1
  • 7Rusthoven KE, Kavanagh BD, Cardenes H,et al. Multi-institutional phase 1/11 trial of stereotactic body radiation therapyfor liver metastases. J Clin Oncol. 2009 ,27( 10) : 1572-1578. 被引量:1
  • 8Kim MS, Yoo SY, Cho CK et al. Stereotactic body radiationtherapy using three fractions for isolated lung recurrence fromcolorectal cancer. Oncology ,2009 ,76( 3 ) :212-219. 被引量:1
  • 9van der Pool AE, Mendez Romero A, Wunderink W, et al.Stereotactic body radiation therapy for colorectal liver metastases.Br J Surg, 2010,97(3) :377-382. 被引量:1
  • 10Yautrave-Dewsa C,Dewas C , Bonodeau F, et al. Image-guidedrobotic stereotactic body radiation therapy for liver metastases : isthere a dose response relationship?. Int J Radiat Oncol BiolPhys,2011,81(3) e39 - e47. http://www. ncbi. nlm. nih. gov/pubmed/? term = 21377292. 被引量:1

同被引文献21

引证文献2

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部